Andrew Namkung is an attorney in Holland & Knight's Boston office and a member of the firm's Healthcare & Life Sciences and Mergers and Acquisitions Teams. He advises clients on a wide range of healthcare issues, including fraud, abuse, compliance, pricing, reimbursement and transactional matters. Mr. Namkung has experience counseling a wide range of clients in the healthcare industry, including manufacturers, pharmacy benefit managers, pharmacy chains, managed care organizations and healthcare information technology companies.
Mr. Namkung frequently advises clients on complex business relationships and joint ventures within the healthcare industry, in particular, to comply with healthcare fraud and abuse laws. Mr. Namkung has experience in conducting internal investigations as well as responding to inquiries by the Office of Inspector General and the U.S. Department of Justice. On the transactions side, he has performed targeted healthcare regulatory diligence and licensure analysis in connection with healthcare mergers, acquisitions and investments.
Mr. Namkung is well-versed in matters involving federal and state anti-kickback statutes, Stark Law and the False Claims Act (FCA) in both transactional and litigation contexts. Moreover, he has experience navigating the Food, Drug, and Cosmetics Act (FD&C Act), Controlled Substances Act (CSA), and the Health Insurance Portability and Accountability Act (HIPAA).
At the firm, Mr. Namkung is a member of the Hiring Committee for the Boston office. Outside of the firm, he is a member of the Boston Bar Association's New Lawyers Section Steering Committee as the liaison to the Health Law Section.
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.